Cardiff Oncology
CRDF
CRDF
68 hedge funds and large institutions have $12.1M invested in Cardiff Oncology in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% less capital invested
Capital invested by funds: $40M → $12.1M (-$28M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $182K
Holders
68
Holding in Top 10
–
Calls
–
Puts
$182K
Top Buyers
| 1 | +$580K | |
| 2 | +$253K | |
| 3 | +$170K | |
| 4 |
Morgan Stanley
New York
|
+$158K |
| 5 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$143K |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$1.35M | |
| 3 | -$456K | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$220K |
| 5 |
Goldman Sachs
New York
|
-$154K |